NCT07142941 is a NA clinical trial of HMB in Diabetes, sponsored by Wu Shangling.

Who is sponsoring NCT07142941?

NCT07142941 is sponsored by Wu Shangling.

What drugs are being tested in NCT07142941?

Interventions in NCT07142941: HMB, Exercise, Placebo, Education.

What condition does NCT07142941 study?

NCT07142941 studies Diabetes, Low Muscle Mass.

Is NCT07142941 still recruiting?

NCT07142941 is currently not yet recruiting. Last updated 31 March 2026.

Last reviewed 2026-03-31 · How we verify

NCT07142941

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Exercise and/or HMB in Older Diabetes With Low Muscle Mass

Not yet recruiting NA Last updated 31 March 2026

What this trial tests

NA trial testing HMB in Diabetes in 120 participants. Not yet recruiting.

Timeline

1 April 2026

Primary endpoint
31 December 2027

31 December 2027

Quick facts

Lead sponsor	Wu Shangling
Phase	NA
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	randomized
Design	factorial
Masking	quadruple
Primary purpose	treatment
Enrollment	120
Start date	1 April 2026
Primary completion	31 December 2027
Estimated completion	31 December 2027

Drugs / interventions tested

HMB — full drug profile →
Exercise
Placebo
Education

Conditions studied

Diabetes — all drugs for Diabetes →
Low Muscle Mass — all drugs for Low Muscle Mass →

Sponsor

Wu Shangling

Who can join

Adults 60 to 80, any sex, with Diabetes or Low Muscle Mass. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators aimed to examine if β-hydroxy-β-methylbutyrate (HMB) supplementation enhances the effects of exercise on muscle mass, physical performance and insulin resistance and observe potential residual effects in older diabetes with low muscle mass, and to find the optimal treatment plan.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of HMB

Trials testing the same drug.

NCT07171593 — High-protein Oral Nutrition With HMB for Active CD Patients With Sarcopenia · NA · enrolling by invitation
NCT05515900 — Salt and HMB Study · NA · unknown
NCT03692507 — Effects of Nutritional Preconditioning on the Patient's Outcomes After Surgery · NA · unknown
NCT03782155 — Effect of Supplementation With HMB and Glutamine in Wound Healing on Bloody Areas · Phase 4 · unknown

Other recruiting trials for Diabetes

Currently open trials in the same condition.

NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
NCT07479134 — Production of Stem Cells for the Generation of Pancreatic Cells · NA · recruiting
NCT07441655 — Families Implementing Good Health Traditions for Life · NA · recruiting
NCT06724172 — CHIME: Comparing Health Interventions for Maternal Equity · NA · recruiting
NCT07417865 — ECHO Diabetes FQHC · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07142941 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Wu Shangling
Last refreshed: 31 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07142941.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing